Securities code: Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) securities abbreviation: Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) announcement No.: 2022024 Wanbangde Pharmaceutical Holding Group Co.Ltd(002082)
Supplementary announcement on the change of financial advisor sponsor
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) (hereinafter referred to as “the company” or ” Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) “) disclosed the announcement on the change of the sponsor of the financial adviser (Announcement No.: 2022023) on April 23, 2022. The sponsor of the independent financial adviser for the sale of major assets of the company in 2020 was changed to Mr. Sun Hongke and Ms. Xu panhui. The resumes of Mr. Sun Hongke and Ms. Xu panhui are disclosed as follows:
Mr. Sun Hongke: now he is the Senior Deputy business director, sponsor representative and certified public accountant of Caitong Securities Co.Ltd(601108) SME financing department. He has many years of working experience in investment banking and has been mainly responsible for or participated in the following projects: Lude medical selected layer listing project, Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) major asset restructuring project, Hengpu science and technology innovation board IPO project, etc.
Ms. Xu panhui: now she is the project manager of Caitong Securities Co.Ltd(601108) SME financing department. Participated in new Ganjiang pharmaceutical, Dingfeng technology and other projects listed on the Beijing stock exchange and private placement.
It is hereby announced.
Wanbangde Pharmaceutical Holding Group Co.Ltd(002082) board of directors
April 25, 2002
